Arterial stiffness is an established cardiovascular risk factor influencing haemodynamic properties in the microcirculation. We tested the hypothesis that increased arterial stiffness is associated with an increase in cerebrovascular resistance in the elderly. Brachialankle pulse wave velocity (baPWV), using arterial tonometry, and anterior cerebral blood flow (aCBF), using extracranial ultrasound, were measured in 26 participants (67-92 years). Non-parametric statistics examined relationships between age, blood pressure, baPWV, cerebrovascular resistance (CVRi) and aCBF. Bivariate analysis suggested that baPWV was the only vascular characteristic associated with CVRi (r s ¼ 0.59; P ¼ 0.002). CVRi was strongly correlated with aCBF (r s ¼ À0.89; Po0.001). Furthermore, compared with participants in the lower three quartiles of baPWV (LO) ; P ¼ 0.09). This study found a positive correlation between baPWV and CVRi in the elderly, suggesting that haemodynamic characteristics associated with arterial aging influence cerebral circulation.
Introduction
Arterial stiffness describes a functional characteristic of the vascular network that has become an established risk factor widely associated with cardiovascular 1,2 and cerebrovascular 3 events. Compared with more compliant vessels in the young, stiffer vessels found with aging are less capable of cushioning arterial pressure pulsations, and subsequently transmit these pressure waves to the distal, more fragile, microvasculature. 4 Stiffness is also associated with endothelial dysfunction and atherosclerotic changes 5, 6 in central and peripheral vessels. Thus, a functional adaptation to stiffer vessels seems to contribute to an altered haemodynamic profile and regulatory capacity that might be deleterious to the microcirculation and subsequent target organ perfusion. To date, examination into the haemodynamic impact of elevated arterial stiffness has been focused within the coronary 7 and peripheral circulations. 8 Despite an observed correlation between pulse wave velocity (PWV) and the severity of disease in small cerebral vessels, 9 the relationship between arterial stiffness, cerebrovascular resistance and cerebral blood flow (CBF) remains largely unexplored.
The brain might be at particular risk to altered haemodynamic characteristics because it is a lowresistance circulatory bed, in which pulsations can travel further into the microvasculature. 10 The current literature provides indirect evidence of an association between arterial stiffness and CBF. 11, 12 Six months of anti-hypertensive treatment resulted in not only a reduced perfusion pressure and increased common carotid distensibility, but also an elevated CBF velocity. 11 Furthermore, in young adults, an acute increase in arterial stiffness and attenuation of CBF was observed following the administration of the endogenous nitric oxide (NO) synthase inhibitor asymmetric dimethylarginine. 12 This study was designed to test the hypothesis that elevated arterial stiffness in an elderly population is associated with elevated cerebrovascular resistance and reduced CBF.
Materials and methods

Participants
Twenty-six elderly individuals (67-92 years) volunteered to participate in this study. Participants were functionally independent and recruited from assisted-living facilities and the community. Each participant provided written, informed consent to participate in this study. All procedures were reviewed and approved by the Office of Research Ethics at the University of Waterloo.
The participants were familiarized with the testing procedures during a preliminary orientation session at the time of informed consent. Individuals presenting with possible carotid stenosis during ultrasound examination (systolic peak velocity 4100 cm s À1 ) were excluded from the study. Participants were considered hypertensive if their resting systolic blood pressure was greater than 140 mm Hg, or diastolic blood pressure was greater than 90, or if they self-reported taking anti-hypertensive medication (n ¼ 13). All measures were taken in the morning with abstention from caffeine and exercise for at least 3 h, before collection. They were permitted to eat a light breakfast (for example, piece of toast, fruit juice) the morning of the test. All measurements were made following acclimatization (B10 min) to a supine position.
Heart rate (electrocardiogram; Pilot 9200, Colin Medical Instruments, San Antonio TX, USA) and mean arterial blood pressure (MAP; finger-cuff photoplethysmography; Finometer, Finapres Medical Systems, Amsterdam, the Netherlands) were measured continuously at 1 kHz using data acquisition hardware (Powerlab, AD Instruments, Colorado Springs, CO, USA) and the associated software (Chart v5.4.2, AD Instruments). Finometer reconstruction of brachial artery pressure has been validated against intra-arterial pressures. 13 Pulse pressure at the left common carotid (cPP) was measured over consecutive beats using applanation tonometry (SPT-301, Millar Instruments, Houston TX, USA). Optimal pulse wave contour was determined visually by maximizing the signal amplitude, and minimizing the pulse and diastolic pressure variation.
14 To correct for hold down pressure, the mean and diastolic tonometric signals were calibrated to the mean and diastolic pressures measured by Finometer. Only small changes in mean or diastolic blood pressure have been reported between the aortic and radial branches of the arterial tree. 14 
Pulse wave velocity
Arterial pressure wave contours were obtained sequentially from the superficial brachial and posterior tibial arteries using applanation tonometry. Fifteen consecutive pressure waves were bandpass filtered to identify the foot of each wave. 15 For each site, the timing of the foot of the pressure wave was registered relative to the R-spike in the QRS complex. 16 The difference in time for the foot of the wave to reach each site was calculated (T BA ). The path lengths from the suprasternal notch to the brachium (L B ) and ankle (L A ) were determined by direct superficial measurement. Brachial-ankle PWV (baPWV) was calculated as the difference in path length divided by the difference in transit time between the two sites: baPWV ¼ (L A -L B )/T BA . All reported values are taken from the left side.
Cerebral blood flow
Global anterior CBF (aCBF) was quantified using extracranial Doppler ultrasound measured bilaterally at the internal carotid arteries. Measurements were made 1-2 cm distal to the carotid bifurcation with the participant's chin slightly elevated and head turned 10-201 to the contralateral side for greater exposure of the artery. Brightness-mode echo ultrasonography using a 6-13 MHz linear array transducer (HFL38, MicroMaxx, Sonosite Inc, Bothell, WA, USA) was used to obtain images of internal carotid arteries diameter. Doppler function with the same probe allowed measurement of mean flow velocity (MFV). Angle correction of velocity measures ranged from 55 to 701. Diastolic vessel diameter was measured in triplicate and MFV (time averaged mean of B10 consecutive cardiac cycles) was measured in duplicate. The average values were used in the calculation mean blood flow (MBF) through each vessel, where
2 . The sum of MBF through the bilateral internal carotid arteries was used as an estimate of aCBF. An index of cerebrovascular resistance (CVRi) was calculated from MAP/aCBF.
Statistical analysis
Non-parametric statistics were used to provide a conservative analysis of the data, given the small sample size and non-normal distribution of some variables. CVRi and aCBF were examined for significant bivariate relationships with age, MAP, cPP and baPWV using Spearman rank correlations (r s ). Wilcoxon two-sample tests were used to compare between hypertensive status and between levels of arterial stiffness (that is, top quartile vs lower three quartiles), where appropriate. Data are expressed as median (interquartile range). Significance was set at Po0.05. All statistical analyses were completed using Statistical Analysis Software v9.1 (SAS Institute, Cary, NC, USA).
Results
Participant characteristics are presented in Table 1 . There were more hypertensive women (9/13) than men (4/13). However, aside from having an elevated cPP, women had similar characteristics to the men (comparisons not shown). Bivariate analysis did not find a relationship between aCBF and age within the whole sample (r s ¼ À0.24; P ¼ 0.25).
Although there was not a significant relationship between aCBF and age, aCBF tended to correlate with baPWV (r s ¼ À0.36; P ¼ 0.07; Figure 1 ). Additionally, baPWV was the only vascular characteristic that significantly correlated with CVRi (r s ¼ 0.59; P ¼ 0.002; Figure 2 ). This relationship held for normotensives (r s ¼ 0.67; P ¼ 0.01), and was close to the criterion of significance for hypertensives (r s ¼ 0.53; P ¼ 0.06). aCBF was not correlated with MAP (r s ¼ 0.14; P ¼ 0.48), but aCBF was strongly correlated with CVRi (r s ¼ À0.89; Po 0.0001; Figure 3 ). 
Discussion
Increased arterial stiffness with aging is associated with greater arterial pulse pressure. It has been proposed that the transmission of elevated pulse pressures to the microcirculation, especially in regions with relatively low vascular resistance such as the brain or kidney, are deleterious to the vascular beds of these target organs. 10 Consistent with our hypothesis, we found that increased baPWV was significantly related to an increase in CVRi, and that this was strongly related to a reduction in CBF, in the elderly.
The baPWV values reported here are generally lower than have been noted earlier in the elderly. Although Yu et al. 17 reported an average baPWV of 10 m s À1 in a predominantly middle-aged cohort, Yamashina et al. 18 found that 70% of individuals older than 60 years of age had a baPWV over 14 m s À1 . Only 20% of our participants were noted to be above this value suggesting that this group of participants had generally good vascular health.
Lower CBF is normally found with aging, 19 yet cerebrovascular autoregulation remains intact, 20 
Abbreviations: aCBF, anterior cerebral blood flow; ACE, angiotensin converting enzyme; AII, angiotensin II; BaPWV, brachial-ankle pulse wave velocity; cPP, common carotid artery pulse pressure; CVRi , cerebrovascular resistance index; MAP, mean arterial pressure. All data are presented as median (interquartile range). P-value refers to hypertensive status comparison. maintaining relatively constant CBF in the face of acute changes in arterial pressure (that is, MAP). In this study, there was a trend for lower CBF with increasing age, and across the study population, CBF was independent of MAP. There were, however, large differences in CBF between individuals that were accounted for by CVRi. The two measured variables, CBF and MAP, are inextricably linked to one another through CVRi by the Ohm's Law relationship; 21 thus, it was not unexpected to see that CBF was lower when CVRi was elevated. With acute changes in MAP, cerebrovascular autoregulation uses changes in CVRi to maintain CBF. 22 The novel finding in this study was that a chronic condition such as increased arterial stiffness correlated with increased CVRi and was associated with reduced CBF. A corollary of these relationships is that age-related attenuation in CBF could be at least partially a consequence of altered haemodynamic properties, independent of neuronal atrophy. 23 This is consistent with the literature relating hypertension to cerebral hypoperfusion 24 and arterial stiffness to cerebral small vessel disease. 9 There were no apparent differences between normotensives and hypertensives. This could be due to the confounding effect of medications not only on mean arterial pressure, but also on arterial stiffness. 11 Differential effects of the medications listed in Table 1 could not be determined because of the small sample size.
There are two pathological determinants that could mediate the relationship between altered haemodynamic stresses with increased CVRimicrovascular remodelling and impaired vasomotor regulation. Arterial stiffness has been associated with arteriolar remodelling within peripheral tissues. [25] [26] [27] In humans free of overt cardiovascular disease, elevated arterial stiffness was associated with a smaller lumen diameter in the retinal vasculature, a commonly used surrogate for cerebral vessels. 25, 26 Additionally, luminal narrowing has been directly observed in the frontal cortex of spontaneously hypertensive rats. 27 These structural changes reported from both human and animal studies are consistent with our finding of increased CVRi. In this study, there was no definitive relationship between CVRi and either absolute MAP or cPP. It is possible that the use of anti-hypertensive medications confounded the interpretation of these data. Future investigations are required to explore the mechanism linking increased stiffness to structural changes in cerebral vessels.
An alternative or parallel pathway to the remodelling could involve the NO system and impairment of vasomotor regulation. Bioavailability of NO, a key metabolite in the regulation of CBF, 28 is dependent on a healthy vascular endothelium and the absence of NO-quenching reactive oxygen species. Arterial stiffness has been related to endothelial dysfunction in the forearm vasculature; 29 however, this relationship has not been studied in cerebral vessels and it is unknown whether this mechanism might be involved in the observed increase in CVRi.
To further characterize the impact of increased arterial stiffness on cerebrovascular function, we compared participants in the top quartile of baPWV to the lower three quartiles. This division revealed a clear separation with elevated CVRi and a strong trend to lower CBF in those categorized as having stiffer arteries. The individuals included in this upper quartile had values of baPWV that approached or exceeded 14 m s À1 , which has been shown to be a threshold for atherosclerotic risk stratification. 18 The brain is a highly metabolic organ with a low energy storage capacity, making it very dependent on the delivery of oxygen and glucose through adequate CBF. Even a slight reduction in CBF that is not mediated by changes in metabolic demand, but rather by neuron-independent vascular changes associated with increased arterial stiffness could place brain tissue at risk for ischemic damage. In experiments using a rat model, artificially imposed cerebral hypoperfusion resulted in elevated levels of white matter damage 30 -an observation consistent with clinical associations of white matter hyperintensities and low CBF. 31 Hypoperfusion is likely to be particularly damaging to sub-cortical, watershed regions of the brain in which capillary density is sparse and blood flow is low under normal conditions. 32 The observation by Lipsitz et al.
11 that aggressive treatment of earlier uncontrolled hypertensive patients could result in an increased CBF velocity, a reduction in the Doppler indicator of CVRi and an increase in carotid distensibility suggest that reductions in CBF in chronic conditions might be reversible. In this study population, CBF was independent of MAP in a mixed group of normotensive and controlled hypertensive individuals. However, CVRi was strongly correlated with baPWV resulting in lower CBF with increased arterial stiffness. This leads to two important proposals for cerebrovascular health. The first is that prevention of, or slowing the rate of, arterial stiffness progression with aging, for example by increased physical activity, 33, 34 might be a critical factor in maintaining CBF. The second is that individuals with elevated arterial stiffness might benefit from treatments 11 designed to reduce arterial stiffness that might in turn reduce CVRi allowing an increase in CBF.
The findings reported here need to be viewed with caution, as this study was only exploratory in nature, with a small sample size and cross-sectional design. Still, the main variables were shown to be highly correlated using robust non-parametric statistics. As with any correlational study, we cannot make definitive statements regarding causation, but are limited to suggesting associations between arterial stiffness, CVRi and brain blood flow. This report adds to the recent literature linking arterial stiffness with cerebrovascular disease. 9, 35, 36 Notably, Kim et al. 9 found elevated baPWV in hypertensive patients with either symptomatic or asymptomatic subcortical infarction, whereas Choi et al. 35 reported increased baPWV in ischemic stroke patients compared to age and sex-matched controls. In addition, certain regions of the brain might be more susceptible to increased arterial stiffness. Elevated baPWV has been associated with periventricular, but not deep, white matter lesions in a cohort of elderly, asymptomatic individuals. 36 Further work to track changes in arterial stiffness, CVRi and CBF over time, and to examine the impact of arterial stiffness treatment seems warranted.
We used non-invasive technologies that can be easily applied to larger sample sizes and longitudinal studies. baPWV reaches further over the arterial tree and likely includes functional properties from both central and peripheral vessels, whereas other techniques rely heavily on central vessels. 17 Although it has been recommended that arterial stiffness be quantified with carotid-femoral pulse wave velocity, 37 the efforts to reverse increased arterial stiffness are expected to be mediated largely through changes in the peripheral muscular arteries as central elastic arteries have generally irreversible structural changes. 38 The benefit of reducing muscular artery stiffness is a reduction in magnitude of both the reflected waves and peripheral vascular resistance, resulting in a lower pressure through the central arteries. This reduced pressure subsequently improves central arterial stiffness. 39 In addition, extracranial ultrasound has the advantage of providing a full quantitative analysis of blood flow rather than the semi-quantitative approach of transcranial Doppler ultrasound, which relies on an assumption of vessel cross-sectional area, making the extracranial approach more suitable for longitudinal studies. However, neither of these methods provides information on regional cerebral perfusion (that is, flow relative to tissue mass).
In summary, we found, in an elderly population, that elevated arterial stiffness was strongly associated with an increase in CVRi, which was in turn very strongly correlated with a reduction in aCBF. The increase in CVRi might be the result of structural or functional changes in the cerebral circulation, which are a consequence of age-related alterations in haemodynamic properties associated with stiffer central and peripheral arteries. From the data presented here, we are unable to determine whether the elevated resistance is secondary to structural or functional alterations, or both; however, these observations were consistent with our hypothesis that increased arterial stiffness might be a causative factor for reduction in CBF with aging. Further research is required to determine whether the reductions in CBF that we measured constitute cerebral hypoperfusion that puts the brain at increased risk for stroke and dementia, and whether prevention of arterial stiffness progression or its reversal, might reduce this risk.
